Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: dyspnea major surgical or invasive procedure: - cabgx3 (lima->left anterior descending artery, vein->obtuse marginal, vein->posterior descending artery); mvr(27mm mosaic porcine valve) history of present illness: 66 y/o female with known artery disease and moderate mr. admitted for congestive heart failure. work-up at that time revealed severe mr artery disease. she was thus referred to dr. for surgical management. past medical history: - artery disease status post mi , -hypertension -congestive heart failure (ef 20-25% in , 50% in , 35% in ) -chronic renal insufficiency (baseline cr 1.9-2.1 in , 3.8 on discharge in , 2.8 on discharge ) -diabetes mellitus type ii -chronic back pain social history: she has a 30 pack-year history of smoking; she quit in . she does not consume etoh. denies illicit substance use. she lives alone and has five daughters. family history: no family history of cad or dm. physical exam: 72 sr (r) 88/64 (l) 130/60 gen: nad heent: ncat, perrl, anicteric sclera, op benign neck: supple, from, no jvd lungs: cta heart: rrr, nl s1-s2, iii/vi sem abd: obese, nt, nd, nabs ext: no varicosities, 2+ pulses, warm, no edema. neuro: nonfocal pertinent results: 07:05am blood wbc-6.4 rbc-2.98* hgb-8.6* hct-26.6* mcv-89 mch-28.9 mchc-32.4 rdw-16.3* plt ct-188 07:05am blood plt ct-188 07:05am blood glucose-112* urean-56* creat-2.8* na-139 k-4.5 cl-106 hco3-22 angap-16 07:05am blood calcium-8.4 phos-4.2 mg-2.5 - echo pre-cpb: 1. the left atrium is markedly dilated. no spontaneous echo contrast is seen in the body of the left atrium. no spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. no mass/thrombus is seen in the left atrium or left atrial appendage. 2.no spontaneous echo contrast is seen in the body of the right atrium. no atrial septal defect is seen by 2d or color doppler. 3.left ventricular wall thicknesses are normal. the left ventricular cavity is moderately dilated. no left ventricular aneurysm is seen. there is mild to moderate regional left ventricular systolic dysfunction with global hypokinesis especially of the anterior and inferoseptal walls.. no masses or thrombi are seen in the left ventricle. 4.right ventricular chamber size and free wall motion are normal. 5.there are simple atheroma in the aortic root. there are simple atheroma in the ascending aorta. there are simple atheroma in the aortic arch. there are complex (>4mm) atheroma in the descending thoracic aorta. 6.there are three aortic valve leaflets. the aortic valve leaflets are moderately thickened. there is mild aortic valve stenosis (area 1.2-1.9cm2). trace aortic regurgitation is seen. 7.the mitral valve leaflets are moderately thickened. the mitral valve leaflets do not fully coapt. no mass or vegetation is seen on the mitral valve. moderate to severe (3+) mitral regurgitation is seen. the jet is central. there annulus is not dilated. there is bileaflet retraction with moderate mac. post-cpb: pt is on epinephrine infusion. well-seated bioprosthetic valve in the mitral position with no mitral regurgitation seen. lvef now 40% on inotropic support. aortic valve now measures 1.9 cm2 , improved from pre-cpb. mild as trace ai. cxr: there has been interval removal of a left-sided chest tube as well as interval removal of a nasogastric tube and removal of a swan-ganz catheter, with the right internal jugular sheath remaining in place. there is no evidence of pneumothorax. the mediastinal contours appear improved, but with a persistent postoperative appearance. no region of consolidation is seen. pulmonary vascularity appears improved since the prior study. the right costophrenic angle has been excluded from the film. brief hospital course: ms. was admitted to the on for surgical management of her mitral valve and artery disease. she was taken to the operating room where she underwent artery bypass grafting to three vessels and a mitral valve replacement using a 27mm mosaic porcine valve. postoperatively she was taken to the cardiac surgical intensive care unit for monitoring. on postoperative day one, she awoke neurologically intact and was extubated. beta blockade and aspirin were resumed. on postoperative day two, she was transferred to the step down unit for further recovery. she was gently diuresed towards her preoperative weight. the physical therapy service was consulted for assistance with he postoperative strength and mobility. ms. continued to make steady progress and was discharged to rehab on postoperative day #6. she will follow-up with dr. , her cardiologist and her primary care physician as an outpatient. medications on admission: 1. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 2. ezetimibe 10 mg tablet sig: one (1) tablet po daily (daily). 3. levothyroxine 75 mcg tablet sig: one (1) tablet po daily (daily). 4. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily). 5. epoetin alfa 10,000 unit/ml solution sig: one (1) injection qmowefr (monday -wednesday-friday). 6. calcium carbonate 500 mg tablet, chewable sig: 1.5 tablet, chewables po tid (3 times a day). 7. hydralazine 25 mg tablet sig: 1.5 tablets po q6h (every 6 hours). 8. amlodipine 2.5 mg tablet sig: one (1) tablet po daily (daily). 9. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 11. continue on your home insulin dose of humalog, as before. 12. lasix 80 mg tablet sig: one (1) tablet po once a day. discharge medications: 1. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 4. levothyroxine 75 mcg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. ferrous gluconate 300 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 7. ezetimibe 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 8. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*50 tablet(s)* refills:*0* 9. calcium carbonate 500 mg tablet, chewable sig: 1.5 tablet, chewables po tid (3 times a day). disp:*135 tablet, chewable(s)* refills:*2* 10. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 11. lasix 40 mg tablet sig: one (1) tablet po twice a day for 7 days. tablet(s) 12. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours) for 7 days. capsule, sustained release(s) 13. epoetin alfa 10,000 unit/ml solution sig: one (1) injection qmowefr (monday -wednesday-friday). discharge disposition: extended care facility: & rehab center - discharge diagnosis: cad/mr s/p cabgx3 and mvr(27mm porcine) cardiomyopathy cri htn diabetes chf myocardial infarction discharge condition: stable discharge instructions: 1) monitor wounds for signs of infection. these include redness, drainage or increased pain. 2) report any fever greater then 100.5. 3) report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week. 4) no lotions, creams or powders to incision until it has healed. you may shower and wash incision. no bathing or swimming for 1 month. use sunscreen on incision if exposed to sun. 5)no lifting greater then 10 pounds for 10 weeks. 6)no driving for 1 month. followup instructions: follow-up with dr. in 1 month. ( provider: , md phone: date/time: 10:40 follow-up with dr. in 2 weeks. follow-up with dr. in weeks. call all providers for appointments procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries open and other replacement of mitral valve with tissue graft diagnoses: other primary cardiomyopathies coronary atherosclerosis of native coronary artery mitral valve disorders congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 

Answer: The patient is high likely exposed to